Previous reports from examining patients in western countries have reported EGFR T790M mutation in 49–69 % patients with NSCLC harboring EGFR mutations who had undergone rebiopsy after developing acquired resistance to EGFR-TKIs [11, 12, 20]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.